Tocilizumab

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tocilizumab, Thyroid Associated Ophthalmopathy Trial in Guangzhou (Tocilizumab)

Recruiting
  • Tocilizumab
  • Thyroid Associated Ophthalmopathy
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Oct 11, 2023

Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA

Active, not recruiting
  • GCA
  • +3 more
  • Tocilizumab 162Mg/0.9Ml Autoinjector
  • Reggio Emilia, Emilia Romagna, Italy
    Ausl-Irccs - S.C. Di Reumatologia
May 26, 2022

Tocilizumab in Covid-19 Penumonia in Buenos Aires City

Completed
  • COVID-19 Pneumonia
  • Tocilizumab
    • Buenos Aires, Argentina
      Nazareno Galvalisi
    May 16, 2022

    Takayasu Arteritis, Tocilizumab, Adalimumab Trial in Shanghai (Tocilizumab, Adalimumab)

    Recruiting
    • Takayasu Arteritis
    • +3 more
    • Tocilizumab
    • Adalimumab
    • Shanghai, Shanghai, China
      Department of Rheumatology in Zhongshan hospital, Fudan Universi
    Aug 7, 2021

    Tocilizumab in Patients With Severe COVID-19

    Recruiting
    • Severe COVID 19 Pneumonia
    • Tocilizumab
    • Ciudad autónoma de Buenos Aires, Caba, Argentina
      Hospital Italiano de Buenos AIres
    Jun 10, 2021

    Tocilizumab, COVID-19, Critical Care Trial in Trabzon (Tocilizumab)

    Completed
    • Tocilizumab
    • +3 more
    • Trabzon, Turkey
      Karadeniz Technical University
    May 18, 2021

    Cytokine Release Syndrome (CRS) in COVID-19

    Unknown status
    • Covid-19
    • +4 more
    • Wuhan, Hubei, China
      Tongji Hospital
    Mar 16, 2020

    Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in

    Completed
    • Arthritis, Rheumatoid
    • +2 more
      • Bordeaux, Aquitaine, France
        Rheumatology department - Bordeaux University Hospital
      Jan 8, 2019

      Rheumatoid Arthritis, Tocilizumab Trial in Tel Aviv (Tocilizumab)

      Unknown status
      • Rheumatoid Arthritis
      • Tocilizumab
      • Tel Aviv, Israel
        Department of Rheumatology, Tel Aviv Medical Center
      Dec 23, 2018